Application of Alginate-Based Hydrogels in Hemostasis
Yue Xie1, Pan Gao1, Fangfang He1
1Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Gels (Basel, Switzerland)
|February 24, 2022
Summary
Alginate hydrogels offer excellent biocompatibility and hemostatic properties for managing bleeding. This review explores their potential in clinical applications, addressing limitations and future prospects for improved patient outcomes.
Area of Science:
- Biomaterials Science
- Medical Engineering
- Hemostasis Research
Background:
- Hemorrhage is a critical clinical complication in trauma and surgery, necessitating effective hemostasis.
- Alginate is a biocompatible, biodegradable polymer with ideal properties for hemostatic applications.
- The clinical use of alginate hydrogels is expanding, with diverse product development.
Purpose of the Study:
- To review the fundamental structure, properties, and history of alginate.
- To summarize the research progress of alginate hydrogels in clinical hemostatic applications.
- To discuss current limitations and future prospects of alginate hydrogels for hemostasis.
Main Methods:
- Literature review of alginate structure, properties, and historical context.
- Analysis of current research on alginate hydrogels in hemostatic product development.
- Discussion of clinical applications, limitations, and future directions.
Main Results:
- Alginate hydrogels exhibit excellent biocompatibility, biodegradability, and hemostatic efficacy.
- A wide range of alginate-based hemostatic products are emerging, including dressings, powders, and injectables.
- Significant progress has been made in leveraging alginate hydrogels for bleeding control.
Conclusions:
- Alginate hydrogels represent a promising biomaterial for effective hemostasis in various clinical settings.
- Continued research and development are crucial to overcome current limitations and fully realize their potential.
- The broad application prospects of alginate hydrogels in hemostasis are significant for improving patient care.
Related Concept Videos
Introduction to Hemostasis
9.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
9.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
972
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
972


